Volume status in CAPD and APD: Does treatment modality matter and is more always better?

Peritoneal Dialysis International

Volumn 27, Issue 6, 2007, Pages 641-644

  Struijk, Dirk G ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE CLEARANCE; EDEMA; EXTRACELLULAR SPACE; FLUID TRANSPORT; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; HYPERTENSION; MORTALITY; NOTE; PRIORITY JOURNAL; SURVIVAL; ULTRAFILTRATION; BODY FLUID; CHRONIC KIDNEY FAILURE; EXTRACELLULAR FLUID; HEART LEFT VENTRICLE HYPERTROPHY; IMPEDANCE; METABOLIC DISORDER; METHODOLOGY; PERITONEAL DIALYSIS;

BODY FLUIDS; ELECTRIC IMPEDANCE; EXTRACELLULAR FLUID; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; WATER-ELECTROLYTE IMBALANCE;

EID: 41049089874     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700607     Document Type: Note

References (36)

1. United States Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
2. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al.; Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-20.
3. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, et al. Effect of Kt/ V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64:649-56.
4. Konings CJ, Kooman JP, Schonck M, Cox-Reijven PL, van Kreel B, Gladziwa U, et al. Assessment of fluid status in peritoneal dialysis patients. Perit Dial Int 2002; 22: 683-92.
5. Oe B, de Fijter CW, Geers TB, Vos PF, Donker AJ, de Vries PM. Diameter of inferior caval vein and impedance analysis for assessment of hydration status in peritoneal dialysis. Artif Organs 2000; 24:575-7.
6. Cocchi R, Degli Esposti E, Fabbri A, Lucatello A, Sturani A, Quarello F, et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14:1536-40.
7. Velasquez MT, Lew SQ, von Albertini B, Mishkin GJ, Bosch JP. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients. Clin Nephrol 1997; 48:341-5.
8. Plum J, Schoenicke G, Kleophas W, Kulas W, Steffens F, Azem A, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 2001; 16:2378-85.
9. Frankenfield DL, Prowant BF, Flanigan MJ, Frederick PR, Bailie GR, Helgerson SD, et al. Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup. Kidney Int 1999; 55:1998-2010.
10. Takeda K, Nakamoto M, Hirakata H, Baba M, Kubo M, Fujishima M. Disadvantage of long-term CAPD for preserving cardiac performance: an echocardiographic study. Am J Kidney Dis 1998; 32:482-7.
11. Faller B, Lameire N. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 1994; 9:280-6.
12. Enia G, Mallamaci F, Benedetto FA, Panuccio V, Parlongo S, Cutrupi S, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant 2001; 16:1459-64.
13. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 2003; 18:797-803.
14. Tzamaloukas AH, Saddler MC, Murata GH, Malhotra D, Sena P, Simon D, et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6:198-206.
15. Nakayama M, Kawaguchi Y; Water and Electrolyte Balance (WEB) Study Group in CAPD. Multicenter survey on hydration status and control of blood pressure in Japanese CAPD patients. Perit Dial Int 2002; 22:411-14.
16. Wong PN, Mak SK, Lo KY, Tong GM, Wong AK. Factors associated with poorly controlled hypertension in continuous ambulatory peritoneal dialysis patients. Singapore Med J 2004; 45:520-4.
17. Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant 2002; 17:1661-6.
18. Gan HB, Chen MH, Lindholm B, Wang T. Volume control in diabetic and nondiabetic peritoneal dialysis patients. Int Urol Nephrol 2005; 37:575-9.
19. Woodrow G, Oldroyd B, Stables G, Gibson J, Turney JH, Brownjohn AM. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 2000; 15:862-6.
20. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G. Can a reduction in extracellular fluid volume result in increased serum albumin in penitoneal dialysis patients? Am J Kidney Dis 2002; 39:872-5.
21. Tonbul Z, Altintepe L, Sozlu C, Yeksan M, Yildiz A, Turk S. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 2003; 23:46-52.
22. Gunal AI, Duman S, Ozkahya M, Toz H, Asci G, Akcicek F, et al. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588-93.
23. Kawanishi H, Hashimoto Y, Nakamoto H, Nakayama M, Tranaeus A. Combination therapy with peritoneal dialysis and hemodialysis. Perit Dial Int 2006; 26:150-4.
24. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
25. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
26. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47:186-92.
27. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
28. Smit W, Struijk DG, Ho-dac-Pannekeet MM, Krediet RT. Quantification of free water transport in peritoneal dialysis. Kidney Int 2004; 66:849-54.
29. Parikova A, Smit W, Struijk DG, Zweers MM, Krediet RT. The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis. Kidney Int 2005; 68:1849-56.
30. Struijk DG, Krediet RT. Sodium balance in automated peritoneal dialysis [Review]. Perit Dial Int 2000; 20(Suppl 2): S101-5.
31. Rodriguez-Carmona A, Fontan MP. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis. Perit Dial Int 2002; 22:705-13.
32. Rodriguez-Carmona A, Perez-Fontan M, Garca-Naveiro R, Villaverde P, Peteiro J. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44:132-45.
33. Bavbek N, Akay H, Altay M, Uz E, Turgut F, Uyar ME, et al. Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients. Perit Dial Int 2007; 27:663-8.
34. Lee JA, Kim DH, Yoo SJ, Oh DJ, Yu SH, Kang ET. Association between serum N-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2006; 26:360-5.
35. de Fijter CW, Oe LP, Nauta JJ, van der Meulen J, Verbrugh HA, Verhoef J, et al. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994; 120: 264-71.
36. Bro S, Bjorner JB, Tofte-Jensen P, Klem S, Almtoft B, Danielsen H, et al. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int 1999; 19:526-33.